Logo

Foundation Medicine

Foundation Medicine, Natera Launch Early Access for Clinical Personalized ctDNA Monitoring Test
Premium

The personalized and targeted tumor assay, also available for research use in clinical trials, provides a surrogate measure of tumor burden from blood samples.

Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug

The companies will develop the FoundationOne CDx test as a companion diagnostic for Boehringer Ingelheim's BI 907828 in the US, Japan, and EU.

Foundation Medicine, Karyopharm Therapeutics Partnering on Endometrial Cancer CDx

The test would help identify patients who have advanced or recurrent TP53 wild-type endometrial cancer and could benefit from the experimental drug Xpovio.

FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek

FoundationOne Liquid CDx, a liquid biopsy test, is the only blood-based CDx approved for the targeted cancer therapy.

FDA Approves Foundation Medicine Assay as CDx for Certain NSCLC Therapies

The FoundationOne Liquid CDx test can be used with Tarceva (erlotinib), Tagrisso (osimertinib), and Iressa (gefitinib), and other TKIs approved in the future.

Nov 22, 2022

Foundation Medicine Probing Tumor Fraction Influence on Negative Liquid Biopsies
Premium

Nov 18, 2022

New Products Posted to GenomeWeb: Foundation Medicine, Cepheid, Thermo Fisher, Olink, More

Sep 21, 2022

Foundation Medicine, Day One Biopharmaceuticals to Develop CDx for Tovorafenib

Sep 12, 2022

Foundation Medicine, Relay Therapeutics to Develop FoundationOne CDx for FGFR2 Inhibitor

Sep 11, 2022

Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients
Premium

Jun 30, 2022

Analysis of Tumor Mutation, Treatment Data Across Cancers Points to Predictive Biomarkers

Jun 10, 2022

Norway's Fledgling Precision Oncology Effort Finding Early Success
Premium

Jun 9, 2022

FDA Approves Foundation Medicine Test as CDx With Roche's Rozlytrek

Jun 6, 2022

Foundation Medicine, Arvinas Partner to Develop CDx For Prostate Cancer Drug

Jun 3, 2022

Foundation Medicine to Provide Comprehensive Genomic Profiling Tests in Lung Cancer Screening Trial

May 9, 2022

Aadi Bioscience Inks NGS Lab Partnerships to Screen Solid Tumor Patients for Fyarro Trial

Apr 12, 2022

In Sixth Year, Project GENIE Diversifying, Integrating Local Ancestry and Enhancing Clinical Data
Premium

Mar 17, 2022

FDA Approves FoundationOne CDx for EGFR Inhibitors to Identify EGFR Mutations in NSCLC

Feb 22, 2022

FDA Approves Foundation Medicine Test as CDx for Merck's Keytruda to Identify MSI-H Solid Tumors

Feb 18, 2022

In Brief This Week: Foundation Medicine, Seegene, SQI Diagnostics, Yourgene, More

Feb 9, 2022

Foundation Medicine, Eli Lilly Ink CDx Development Deal for Retevmo

Dec 8, 2021

Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma

Oct 29, 2021

New Products Posted to GenomeWeb: Roche, Jumpcode Genomics, Mikrogen, More

Oct 15, 2021

People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More

Sep 8, 2021

Foundation Medicine, Science 37 Partner to Develop Home-Based Clinical Trial Model

Breaking News
The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.